Paper

Lactobacillus reuteri for Infants with Colic: A Double‐Blind, Placebo‐Controlled, Randomized Clinical Trial

Published Dec 1, 2017 · Nicole Y. Fatheree, Yuying Liu, Christopher M. Taylor

The Journal of Pediatrics

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

RCT

Study Snapshot

Daily administration of Lactobacillus reuteri strain DSM 17938 is safe in newborn infants with colic, and many will experience resolution within 3 weeks.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Lactobacillus reuteri for Infants with Colic: A Double‐Blind, Placebo‐Controlled, Randomized Clinical Trial

References

Citations